# Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

> **NCT01326923** · PHASE2 · TERMINATED · sponsor: **Louisiana State University Health Sciences Center Shreveport** · enrollment: 7 (actual)

## Conditions studied

- Head and Neck Squamous Cell Cancer

## Interventions

- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT01326923
- **Lead sponsor:** Louisiana State University Health Sciences Center Shreveport
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Principle Investigator left the institution.
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326923, "Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01326923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*